Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1

Simple item page
dc.contributor.authorSeth D. Ludwig
dc.contributor.authorBunyarit Meksiriporn
dc.contributor.authorJiacheng Tan
dc.contributor.authorRakeeb Kureshi
dc.contributor.authorAkhilesh Mishra
dc.contributor.authorKyle J. Kaeo
dc.contributor.authorAngela Zhu
dc.contributor.authorGeorgia Stavrakis
dc.contributor.authorStephen J. Lee
dc.contributor.authorDavid. J. Schodt
dc.contributor.authorMichael J. Wester
dc.contributor.authorDhiraj Kumar
dc.contributor.authorKeith A. Lidke
dc.contributor.authorAndrea L. Cox
dc.contributor.authorHelen M. Dooley
dc.contributor.authorSridhar Nimmagadda
dc.contributor.authorJamie B. Spangler
dc.date.accessioned2025-07-21T06:11:05Z
dc.date.issued2024-03-27
dc.identifier.doi10.1016/j.chembiol.2024.02.014
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/13442
dc.subjectImmune checkpoint
dc.subjectInternalization
dc.subject.classificationCAR-T cell therapy research
dc.titleMultiparatopic antibodies induce targeted downregulation of programmed death-ligand 1
dc.typeArticle

Files

Collections

All